Cargando…

Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer

Intrinsic or developing resistance to chemotherapy drugs including cisplatin (CDDP) remains the major limitation of cancer therapeutic efficacy in cancers. Recently, increasing evidence suggested that long noncoding RNAs (lncRNAs) play a critical role in various biological processes of tumors, and h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Xue, Liu, Jiayi, Zhu, Li, Song, Rongbo, Zhong, Ming, Guo, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579301/ https://www.ncbi.nlm.nih.gov/pubmed/34790046 http://dx.doi.org/10.7150/ijms.64253

Ejemplares similares

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
por: Pabst, T, et al.
Publicado: (2009)

Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’
por: Hou, H-A, et al.
Publicado: (2009)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
por: Yuan, Ji, et al.
Publicado: (2023)

In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis
por: Guo, Hong, et al.
Publicado: (2016)

Targeted regulation of fibroblast state by CRISPR-mediated CEBPA expression
por: Liu, Wei, et al.
Publicado: (2019)

Expression level of CEBPA gene in acute lymphoblastic leukemia individuals
por: Szmajda, Dagmara, et al.
Publicado: (2019)

ID1 and CEBPA coordinate epidermal progenitor cell differentiation
por: Kantzer, Christina Geraldine, et al.
Publicado: (2022)

LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC
por: Cai, Yunshi, et al.
Publicado: (2022)

MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
por: Jiang, Jingwei, et al.
Publicado: (2018)

Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemia
por: Grossmann, V, et al.
Publicado: (2012)

Long-term follow-up of cytogenetically normal CEBPA-mutated AML
por: Pastore, Friederike, et al.
Publicado: (2014)

Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma
por: Setten, Ryan L., et al.
Publicado: (2018)

HoxA9 binds and represses the Cebpa +8 kb enhancer
por: Peng, Lei, et al.
Publicado: (2019)

Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations
por: Xu, Xiaoyu, et al.
Publicado: (2021)

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
por: Su, Long, et al.
Publicado: (2022)

Tumor suppressor CEBPA interacts with and inhibits DNMT3A activity
por: Chen, Xiufei, et al.
Publicado: (2022)

Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis
por: Quintana-Bustamante, Oscar, et al.
Publicado: (2012)

Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia
por: Schardt, Julian A, et al.
Publicado: (2010)

CEBPA-regulated lncRNAs, new players in the study of acute myeloid leukemia
por: Hughes, James M, et al.
Publicado: (2014)

Genetic characterisation of PPARG, CEBPA and RXRA, and their influence on meat quality traits in cattle
por: Goszczynski, Daniel Estanislao, et al.
Publicado: (2016)

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations
por: Volpe, Giacomo, et al.
Publicado: (2019)

CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex
por: Schmidt, Luisa, et al.
Publicado: (2019)

The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages
por: Repele, Andrea, et al.
Publicado: (2019)

Gain-of-Function Effects of N-Terminal CEBPA Mutations in Acute Myeloid Leukemia
por: Schmidt, Luisa, et al.
Publicado: (2020)

Two Novel CEBPA Mutations in a Turkish Patient with Acute Myeloid Leukemia
por: Tokgun, PE, et al.
Publicado: (2021)

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
por: Wakita, Satoshi, et al.
Publicado: (2022)

Acute myeloid leukemia due to germline CEBPA mutation in a Syrian family
por: Wafa, Abdulsamad, et al.
Publicado: (2022)

The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors
por: Cooper, Stacy, et al.
Publicado: (2015)

Novel Mutations in CEBPA in Korean Patients with Acute Myeloid Leukemia with a Normal Karyotype
por: Kim, Sollip, et al.
Publicado: (2012)

In Silico Genetics Revealing 5 Mutations in CEBPA Gene Associated With Acute Myeloid Leukemia
por: Mustafa, Mujahed I, et al.
Publicado: (2019)

Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice
por: Avellino, Roberto, et al.
Publicado: (2022)

Chronic interleukin-1 exposure triggers selection for Cebpa-knockout multipotent hematopoietic progenitors
por: Higa, Kelly C., et al.
Publicado: (2021)

Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications
por: Molina Garay, Carolina, et al.
Publicado: (2022)

Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia
por: Adamo, Assunta, et al.
Publicado: (2022)

lncRNA CEBPA-AS1 Overexpression Inhibits Proliferation and Migration and Stimulates Apoptosis of OS Cells via Notch Signaling
por: Xia, Peng, et al.
Publicado: (2019)

Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report
por: Helbig, Grzegorz, et al.
Publicado: (2014)

CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation
por: Federzoni, Elena A., et al.
Publicado: (2014)

Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML
por: Jakobsen, Janus S., et al.
Publicado: (2019)

The ASXL1-G643Wvariant accelerates the development of CEBPA mutant acute myeloid leukemia
por: D’Altri, Teresa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2dgm68bl2882nukm8n3b09g5g6